← All chemicals

CAS 10045-97-3

Cesium-137 (Cs-137)

RadionuclideGamma EmitterNuclear FalloutCarcinogen

Cesium-137 is the most important gamma-emitting radioisotope from nuclear accidents and weapons testing — responsible for the long-term land contamination after Chernobyl and Fukushima and the reason why exclusion zones remain restricted decades after explosions, while also posing orphaned source dangers from lost medical and industrial devices.

Where It Comes From

Cs-137 is a fission product of uranium and plutonium, produced in nuclear reactors and weapons [1]. The 1986 Chernobyl explosion released 85 petabecquerels of Cs-137 across Europe and the Northern Hemisphere; the 2011 Fukushima accident released approximately 10 petabecquerels [2]. Nuclear weapons testing deposited global Cs-137 fallout from 1945-1980. Cs-137 is also used in medical brachytherapy devices, industrial gauges, and radiological laboratories — 'orphaned' sources (lost, stolen, or abandoned industrial Cs-137 devices) have caused radiation accidents when found by unsuspecting people [1]. The half-life of Cs-137 is 30.2 years, meaning areas contaminated by Chernobyl will not reach background levels until roughly 2086 [2].

How You Are Exposed

Near nuclear accident sites, Cs-137 contaminates soil and vegetation and enters the food chain through leafy vegetables, mushrooms, berries, and grazing animals [1]. Fish in contaminated lakes and rivers accumulate Cs-137. For the general population distant from accident sites, dietary Cs-137 from residual global fallout is very small [2]. External gamma irradiation from contaminated soil is a pathway for people living in or visiting contaminated zones [1]. Contact with orphaned Cs-137 industrial sources is a rare but serious acute exposure scenario [2].

Why It Matters

Cs-137 emits high-energy gamma radiation that penetrates the entire body, irradiating all tissues [1]. Unlike bone-seekers (radium, strontium), Cs-137 distributes throughout soft tissues, with muscle having the highest concentration (Cs mimics potassium in cellular transport) [2]. Internal Cs-137 from ingestion irradiates the whole body from within. The radiological risk is primarily cancer (thyroid cancer — from radioiodine co-released in accidents — leukemia, and solid tumors) [1]. For children evacuated from Chernobyl, thyroid cancer rates increased dramatically from I-131 exposure; solid tumor increases were attributed partly to Cs-137 [2].

Who Is at Risk

Populations living in or near the Chernobyl exclusion zone (Ukraine, Belarus, Russia) had the highest exposures from the 1986 accident [1]. Children and pregnant women are most radiation-sensitive due to higher cellular division rates [2]. Workers involved in nuclear accident cleanup (Chernobyl 'liquidators') had documented elevated exposures and cancer rates [1].

How to Lower Your Exposure

1. Follow official guidance on food consumption and residence restrictions in any radiologically contaminated zone [1]. 2. Potassium iodide (KI) tablets protect only the thyroid from radioiodine (I-131), not from Cs-137 — follow official distribution guidance during nuclear emergencies [2]. 3. For orphaned source encounters: if you find an unknown device with radiation warning symbols, do not touch it; call emergency services [1]. 4. Prussian blue (potassium ferric hexacyanoferrate) is the FDA-approved treatment for internal Cs-137 contamination — reduces Cs-137 biological half-life from 110 to ~30 days [2].

References

  1. [1]WHO (2012). Health effects of the Chernobyl accident. https://www.who.int/news-room/fact-sheets/detail/chernobyl-at-30
  2. [2]FDA (2023). Potassium Iodide as a Thyroid Blocking Agent in Radiation Emergencies. https://www.fda.gov/drugs/bioterrorism-and-drug-preparedness/frequently-asked-questions-potassium-iodide-ki

Recovery & Clinical Information

Body Half-Life

The physical half-life of Cs-137 is 30.2 years, but the biological half-life (time for 50% elimination from the body) is approximately 70-110 days — Cs-137 is distributed throughout body water like potassium and turns over relatively quickly [1]. This means, unlike bone-seeking radionuclides, Cs-137 can be accelerated out of the body using Prussian blue [2].

Testing & Biomarkers

Whole body counting (gamma spectroscopy) measures total body Cs-137 directly [1]. Urinary cesium by ICP-MS or gamma spectroscopy measures excretion rate [2].

Interventions

Prussian blue (insoluble, taken orally) is the FDA-approved treatment for internal Cs-137 contamination — it binds Cs-137 in the gastrointestinal tract, interrupting enterohepatic recirculation and increasing fecal excretion, reducing biological half-life from ~110 days to ~30 days [1]. Adequate dietary potassium may reduce Cs-137 absorption by competitive transport [2].

Recovery Timeline

With Prussian blue treatment, body burden Cs-137 can be reduced by 50% in approximately 30 days [1]. Without treatment, 50% reduction takes ~70-110 days of no re-exposure [2]. Unlike bone-seeking isotopes, Cs-137 clearance is achievable on a months timescale [1].

Recovery References

  1. [1]FDA (2023). Radiogardase (Prussian blue) prescribing information. https://www.fda.gov/media/75463/download
  2. [2]ATSDR (2004). Toxicological Profile for Cesium. https://www.atsdr.cdc.gov/toxprofiles/tp157.pdf

Track your exposure to Cesium-137 (Cs-137)

Pollution Profile maps your lifetime exposure history to EPA-tracked chemicals.

Get early access

We use cookies and analytics to understand how people use Pollution Profile and improve the experience. We never sell your data. Learn more.